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Background: The analysis of protein structures provides fundamental insight into most biochemical functions and
consequently into the cause and possible treatment of diseases. As the structures of most known proteins cannot
be solved experimentally for technical or sometimes simply for time constraints, in silico protein structure
prediction is expected to step in and generate a more complete picture of the protein structure universe.
Molecular modeling of protein structures is a fast growing field and tremendous works have been done since the
publication of the very first model. The growth of modeling techniques and more specifically of those that rely on
the existing experimental knowledge of protein structures is intimately linked to the developments of high
resolution, experimental techniques such as NMR, X-ray crystallography and electron microscopy. This strong
connection between experimental and in silico methods is however not devoid of criticisms and concerns among
modelers as well as among experimentalists.
Results: In this paper, we focus on homology-modeling and more specifically, we review how it is perceived by
the structural biology community and what can be done to impress on the experimentalists that it can be a
valuable resource to them. We review the common practices and provide a set of guidelines for building better
models. For that purpose, we introduce the H-factor, a new indicator for assessing the quality of homology
models, mimicking the R-factor in X-ray crystallography. The methods for computing the H-factor is fully described
and validated on a series of test cases.
Conclusions: We have developed a web service for computing the H-factor for models of a protein structure. This
service is freely accessible at http://koehllab.genomecenter.ucdavis.edu/toolkit/h-factor.
Background
Introduction
Since 1958, when Kendrew et al reported the first
atomic-level resolution of a protein structure (myoglo-
bin), the structural biology field dramatically expanded
with the development of new tools and methods to gain
access into atomic details of a protein or a nucleic acid
[1]. This opened a completely new world of knowledge
and understanding to the scientific community, as the
analysis of protein structures provides fundamental
insight into most biochemical functions and consequently
into the cause and treatment of diseases. Structural
biology is now recognized as a fundamental step in our
quest to understanding life at the molecular level.
Finding the structures of all proteins is currently a
bottleneck for genomics studies. In this matter, the Pro-
tein Structure Initiative (PSI) aims at the determination
of the three-dimensional (3D) structure of approxi-
mately 100,000 structures in 10 years. However, the pro-
tein sequence databank (UniProt/TrEMBL) is growing at
a much faster rate, with more than 10 millions
sequences available to date (March 2010). At the same
time point, the Protein Data Bank (PDB) includes
64,100 structures, out of which only approximately 4300
are “unique” at chain level (i.e. once we remove “redun-
dant” proteins whose sequences have more than 95%
sequence identity with another protein in the PDB). It
should be noted that these structures only represent a
biased sample of the protein universe. For example, the
PDB includes only 220 unique membrane proteins
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around 20-30% of most proteomes [2]. Noteworthy, the
human genome has ~21,000 protein-encoding genes for
a proteome of ~1,000,000 proteins when combining the
complexity induced by alternative slicing events [3]. In
addition, due to experimental limitations, the vast
majority of the solved structures are below the 50 KDa
threshold excluding numerous larger proteins. Large
proteins however represent a significant fraction of the
proteins present in an organism; for instance, proteins
found in yeast Saccharomyces cerevisiae have five hun-
dred amino acid residues on average and their lengths
can reach two thousand eight hundred residues [4]. The
structure of these large proteins, as well as of even lar-
ger assembly can be solved by electron microscopy at a
somewhat low-resolution. While this field is expanding
very fast and a growing number of structures solved at
atomic-level resolution have been reported [5,6], its
impact with respect to the size of the protein sequence
databank remains limited. Many more protein structures
have been solved by either X-ray crystallography or
nuclear magnetic resonance (NMR). It remains however
that most proteins are out-of-reach because of technical
difficulties. There is clearly a huge gap between the
world of known structures and the universe of known
protein sequences. Structural genomic projects are
unable to keep up with newly discovered genes.
One way to work around this problem is to use com-
putational methods to predict proteins structures.
In silico protein structure prediction techniques can be
divided into two categories: the ab-initio folding meth-
ods and homology modeling. In this paper we focus on
the latter. We note that both approaches have been
shown to yield astounding results, as shown in the suc-
cessive CASP contests [7]. However, they do require
caution: while predicting the structure of a protein is an
intellectual challenge that requires solving many practi-
cal issues, it is often considered as an art in essence.
The growth rate of structures deposited in the PDB is
slowing down since 2004, along with the number of new
superfamilies or folds discovered [8,9]. One possible
explanation is that many proteins still evade the struc-
tural biology pipelines at this time because of the tech-
nical difficulties described above. In 1992 Chothia
hypothesized that the number of protein folds in nature
is probably finite and around 1,000 [9,10]. The latest
analysis of the PDB and of the structural classification
of proteins (SCOP) showed that we have not yet reached
a plateau (currently estimat e dt ob ea r o u n d1 , 5 0 0 )[ 8 ] .
The current rate at which proteins are added in the
PDB is far too slow to match with the number of new
protein sequences discovered every year. The situation
is however not so negative. There is a definite hope that
the current content of the PDB will allow us to predict
reliably the correct scaffold of more than 70% of the
whole proteome using in silico methods [11]. This is the
rationale for using homology modeling to complement
experimental techniques.
Homology modeling predicts the structure of a pro-
tein by inference from a homologous protein whose
structure is known (see Figure 1 for a schematic illus-
tration of the technique). Its success rests on (i) the
existence of a homologue with known structure,
(ii) our ability to detect this homologue, and (iii) the
quality of the model building process once the homo-
logue is detected. Steps (i) and (ii) have greatly bene-
fited from the different genomics projects: with the
additional structures generated by the structural geno-
mics projects, sampling of the protein structure space
is becoming finer, improving the chance that a struc-
tural homologue exists for any given protein sequence.
With the parallel increase in the number of sequences
available in genomic databases and the development of
meta-servers to analyze and query sequence databases,
there has been significant improvement in the detec-
tion of homology [12]. In the recent CASP experi-
ments, targets with sequence identity of 6% to their
templates were included int h eH o m o l o g yM o d e l i n g
category [13-15]. There is hope that in the near future
homology modeling will reach its ultimate goal: the
generation of model protein structures as accurate as
those determined by high-resolution experimental
studies.
Biologists unanimously consider X-ray crystallography
as the prime source of structural information on pro-
teins and the “gold standard” in term of accuracy: they
base their confidence on its long list of published suc-
cesses. The vast majority of structures deposited in the
PDB were determined by X-ray crystallography and 14
Nobel prizes in Chemistry and Medicine have been
awarded to crystallographers [16] (For recent reviews,
see Kleywegt and Jones, 2002 [17]; Wlodawer et al,
2007 [16]; Brown and Ramaswamy, 2007 [18]; Ilari and
Savino, 2008 [19]). Homology modeling on its own
however is not devoid of successes. The very first pub-
lished homology model in 1969 was the small protein
a-lactalbumin, which was modeled on the basis of the
structure of hen egg white lysozyme as a template [20]
with the two proteins sharing 39% sequence identity.
When the structure of a-lactalbumin was later solved
by X-ray crystallography [21], the model turned out to
be essentially correct [22]. Since then, homology model-
ing has continuously extended its field of applications,
including designing mutants to test hypotheses about
protein functions, identification of active sites, drug
design, protein-protein docking, facilitating molecular
replacement in X-ray structure determination, refining
models based on NMR constraints (for recent reviews
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Despite these successes, homology modeling is not yet a
well-established alternative or complement to experi-
mental structural biology. It remains the focus of many
criticisms often coming from the structural biologists
themselves as they often consider a protein model to be
unreliable, not being based on experimental data. The
question arises as to what needs to be done to give
homology modeling its credentials.
In this paper, we focus on homology modeling and
more specifically, we review how the structural biology
community perceives it and what can be done to
impress on the experimentalists that it can be a valuable
resource to them. It is organized as follows. The next
section reviews the differences and similarities between
homology modeling and high-resolution experimental
structural biology. In particular, we illustrate steps in
t h eh o m o l o g ym o d e l i n gp r o c e d u r et h a ta r ep u t a t i v e
source of errors. Our goal is to provide a useful step-by
step handbook for non-specialists in order to help build-
ing better model.
The following section introduces the H-factor, a new
indicator for assessing the quality of homology models.
The H-factor is designed to check how well a family of
homology models reflects the data that were used to
generate those models, in the spirit of the R-factors in
X-ray crystallography. The results section that follows
validates the H-factor on a series of test cases. We con-
clude the paper with a discussion on what remains to be
done to make homology modeling a prime technique for
the biologists.
Homology Modeling versus Experimental Structural
Biology
This section reviews briefly the quality of protein struc-
ture models obtained either using high-resolution
experimental techniques or homology modeling. Our
hope is to identify common good practices as well as
safeguards from which we can derive a validation tool
for the latter. We start with the concept of a structural
model and its meaning in the two communities of
experimental and computational structural biologists.
We then highlight the pros and cons of X-ray crystallo-
graphy and NMR spectroscopy. An overview of the dif-
ferent steps involved in homology modeling follows,
with emphasis on sources of errors and how they can be
checked. Ultimately our goal is not to rank these meth-
ods but rather we hope to show that they all provide
Figure 1 A schematic flow chart of the homology modeling method. Example of the T0295 target (Pf-KsgA from Plasmodium falciparum)
from CASP7. The sequence alignment between the sequences of T0295 and the template protein in PDB file 1ZQ9 was generated using
ClustalW V.2.0.10 [87] and the model was built using MODELLER 9v5 [36]. The X-ray structure of T0295 (PDB 2H1R) is displayed within brackets
for visual comparison with one of the T0295 models.
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as the proper safeguards are applied.
What is a model?
The meaning of the word “model” is ambiguous in the
structural biology community. A model for a protein
structure can be obtained either by X-ray crystallogra-
phy, by NMR spectroscopy, by electron microscopy, by
computational methods or by combinations of all or
some of these techniques. With experimental techni-
ques, the atomic coordinates are refined against experi-
mental structural restraints and constraints. Eventually
the final model is called “structure” when the refinement
statistics converge toward acceptable canonical values.
Note that often this final model is subjected to refine-
ment using simulation techniques such as constrained
molecular mechanics or molecular dynamics simula-
tions. Even though these simulations are constrained
with the experimental data, the subsequent “structure”
cannot be considered to be fully independent of model-
ing. On the other hand, an in silico model is generated
without or with very limited experimentally constraints:
it depends obviously on the hypotheses included in the
modeling process, on the force-field used in the simula-
t i o n sa sw e l la so nt h eq u a l i t y of the scientific comput-
ing tools that were used during the modeling steps.
W h i l et h eq u a l i t yo fa n“experimental” model can be
assessed directly against the experimental data, the qual-
ity of an “in silico“ model is more subjective and ulti-
mately defined through the usefulness of the model: this
is most probably the source of the mistrust towards
modeling in general.
X-ray crystallography: source of errors and quality metrics
A number of factors contribute to the quality of an
X-ray structure. The first factor relates to the intrinsic
crystal properties and its diffraction capabilities, which
is mostly evaluated in term of resolution. The quality
metrics used in X-ray crystallography fall into three
categories: 1) to measure the quality of the raw data,
2) to measure the agreement of the refined structure
against the data and 3) to validate only the model for
ideal stereochemistry, rotamers and bad clashes imple-
mented in What Check or Molprobity for instance. The
first category lies upstream of the structure building
process as the measures it includes evaluate the quality
of the experimental diffraction data. The Rsym indicator
for example measures the average spread of individual
measurements in respect to their symmetry equivalent
measurements. A good dataset will have an Rsym smal-
ler than five percent. In addition, the quality of a data-
set is also assessed by its signal-to-noise ratio <I/s(I)>
and its data-collection completion for a given space
group. Unfortunately, only a few crystals diffract to
atomic resolution (under 1 Å) with ideal quality
metrics. Most of the crystal-based structures have
therefore been solved with good to average raw data
quality. Although building a structure can be semi-
automatic with automated tools available for chain tra-
cing, side chain-building, ligand building and water
detection, it is still refined by experimentalists using
their subjective interpretations of the data. It is com-
mon for example to find areas of poorly defined elec-
tron density map due to disordered regions. The
experimentalist interprets these data to the best of her
knowledge but this is unfortunately a common source
of errors. The second set of quality metrics assesses the
relative agreement of the structure in regard to the
experimental data. This set includes the R-factor and
the “free” R-factor (R-free). The R-free is analogous to
the R-factor but uses a small subset of the data that
have been flagged-out and not taken into account dur-
ing any refinement process [26]. Its purpose is to moni-
tor the progress of refinement and to check that the R
factor is not being artificially reduced by the introduc-
tion of too many parameters. As such, it provides an
unbiased indicator of the errors in the structure and
prevents any over-refinement and over-interpretation of
the data. Both factors along with Rsym and Rmerge can
be seen as indicators of the errors inherent in the
refined model and in the experimental data.
The quality of protein crystal structures has been
reviewed several times over the last fifteen years and it
is striking to notice that despite a constant increase of
the technology and validation tools, it has not improved
overall. The quality spectrum of X-ray structures
remains broad. The increase of automation through
structural genomic pipelines did not help raising the bar
in that matter as human intuition and reasoning are
taken out of the process [17,18]. Interestingly, X-ray
structures published in high-impact general science
journals are usually the worse offenders in term of qual-
ity and errors. This is explained by the experimental dif-
ficulties associated with solving novel high profile
structures and the rush to publish in a competitive
environment [18].
X-ray crystallography is not immune to errors and
mistakes, both honest and dishonest. Unfortunately,
over the years we have seen gross mistakes in various
structures leading to the retraction of several high-
impact papers in leading journals because of a lack of
quality control during the structure building pipeline
[27,28]. A recent review by G. J. Kleywegt highlights the
need and the proper use of validation methods in struc-
tural biology in general and in X-ray crystallography in
particular. The author also emphasizes the use of valida-
tion methods early on in the project pipeline in order to
minimize the number of erroneous high-profile struc-
tures that can hinder the progress of science for years to
come [29]. In light of a growing number of structures
di Luccio and Koehl BMC Bioinformatics 2011, 12:48
http://www.biomedcentral.com/1471-2105/12/48
Page 4 of 19falsification and to prevent both dishonest and honest
mistakes in structures determination, the curators of the
PDB have implemented over the years new sets of vali-
dation procedures for the deposition process [30].
NMR spectroscopy: source of errors and quality metrics
Although structure determination by NMR spectroscopy
methods is very different from X-ray crystallography, it
shares similarities with the latter in terms of sources of
errors. Instead of using an X-ray beam diffracting
around electrons in a crystal, NMR spectroscopy is per-
formed in solution and uses the magnetic properties of




the molecule of interest is placed in a strong magnetic
field, each of these nuclei is characterized by a unique
resonance frequency, i.e. the frequency at which it will
absorb energy. This frequency depends on the local
magnetic field that combines the external field and the
local environment: it is referred to as the chemical
shifts. NMR experiments are designed to monitor the
behavior of these nuclei as the system is perturbed from
equilibrium and each experiment usually isolates one
property, such as through-bond connectivity’s( C O S Y
and TOCSY experiments) or spatial proximity that
a l l o w sf o re n e r g yt r a n s f e r( NOESY experiments). In the
specific case of proteins, the number of nuclei involved
can be large, leading to crowding of the spectra: this is
u s u a l l yo v e r c o m eb yu s i n gm u l t i d i m e n s i o n a le x p e r i -
ments (mostly 2 D, but also 3 D and 4D). The typical
protocol for protein structure determination by NMR
proceeds as follows. Firstly, the chemical shifts observed
on multidimensional spectra are assigned to their speci-
fic atoms (nuclei) in the protein (the assignment pro-
cess). Second, through-the-bond and through-space
coupling effects (i.e. J-coupling and Nuclear Overhauser
effects, respectively) observed on these spectra are quan-
tified and concerted into angles and distance restraints.
Most of these restraints correspond to ranges of possible
values instead of a precise constraint. Thirdly, a molecu-
lar modeling technique is used to generate a set of mod-
els for the protein structure that satisfy these
experimental restraints as well as standard stereochemis-
try. For a more detailed presentation of the application
of NMR to protein structure determination, we refer the
reader to [31-34]. Analogously to X-ray methods, the
quality of NMR measurements affects the quality of the
structures. The precision of a set of models for a protein
structure determined by NMR is evaluated as the root-
mean-square (RMS) difference between each model and
a “mean” structure, defined geometrically as the mean
of all the models (note that the stereochemistry of this
mean model is usually not correct). The quality of each
model is evaluated by the number of violations observed
in the model compared to the experimental restraints. A
high-quality NMR structure refers to a set of high
quality models with no violations that are tightly
bundled around their mean, i.e. with a small RMS. Note
that in addition to these NMR specific quality measures,
Garrett and Clore introduced a R-factor and a free R-
factor for the refinement of NMR structures based on
residual dipolar coupling, a long range NMR measure
obtained on proteins that have been partially oriented in
dilute liquid crystals. In similarity with X-ray crystallo-
graphy, the quality spectrum of NMR structures is
broad, with errors and mistakes reported that are inher-
ent to a human based determination process [35].
Homology modeling: source of errors and quality metrics
The general strategy developed for homology-modeling
proceeds through a canonical seven-steps procedure
(Figure 1): (1) Identify the template proteins that share
structural similarity to the target; (2) Align the target
sequence with the templates sequences; (3) Build a sin-
gle framework of spatially aligned template structures
and assimilate the target protein backbone with this fra-
mework; (4) Build the missing backbone elements
(loops) not represented in the template framework; (5)
B u i l dt h et a r g e ts i d ec h a i n s ;( 6 )R e f i n et h em o d e li n
order to minimize unrealistic contacts and strains; and
(7) Evaluate the final refined model for physical tenabil-
ity. To date numerous homology-modeling programs
such as MODELLER [36], SegMod/ENCAD [37], Swiss-
model [38], 3D-Jigsaw [39], BUILDER [40] and Nest
[41] have been developed and many of them have been
embedded into homology-modeling servers to ease the
burden of generating models. Online portals such as
the Protein Structure Initiative (PSI) model portal or the
Swiss-Model Repository bring to the community a large
database of models [42]. The PSI model portal currently
provides 8.2 millions comparative protein models for 3.1
million distinct UniProt entries. Every model comes
with relevant validation data. However those models are
automatically generated without any human interaction
that might render them inaccurate without any extra
validation steps. In the following, we overview each step
of the homology modeling process and highlight poten-
tial sources of errors.
*Steps 1 and 2: template selection and sequence alignment
The selection of template(s) is undoubtedly a critical
step in modeling. It was long assumed that two proteins
whose sequences share at least 40% identity have similar
structures. If such a template exists, it is easily detected
by any sequence alignment techniques. Homology mod-
eling under such conditions is then expected to generate
models whose accuracy is close to that of an experimen-
tal structure. We know however that this is not always
true. Roessler et al. recently reported the discovery of
two native Cro proteins sharing 40% sequence identity
but with different folds [43]. Moreover, Alexander et al.
were able to design two proteins with 88% sequence
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Reversely, it is not uncommon for proteins, especially
enzymes carrying the same function across the tree of
life to share a somewhat low sequence identity and at
the same time being structurally similar, with a Ca r.ms.
d. ~1.5Å [45]. All these observations indicate that the
selection of template is far from being a trivial task and
extreme caution should be applied.
The situation is even more difficult if there is no sig-
nificant sequence similarity between the sequence of the
target protein and any of the known protein structures.
This is one of the current challenges of the post-
genomic era that is tackled by fold-recognition methods,
namely to identify a suitable template for homology
modeling [46-48]. Unlike sequence-only comparison,
fold-recognition techniques take advantage of the infor-
mation made available by 3 D structures. Despite a
steady development over the years, as illustrated through
the successive CASP experiments, fold recognition tech-
niques still have a number of limitations. They are how-
ever the key to extend the domain of application of
homology modeling methods.
The accuracy of the sequence alignment is another cri-
tical step in the homology modeling process [49]. It is
important to keep in mind that a shift of one residue in
the alignment introduces a distortion of 3.8 Å in the
model for the backbone of the target protein (Figure 2A
&2B). Therefore, it is of paramount importance to pre-
cisely verify and locally refine the sequence alignment
used to build a model. For that matter, the areas of
sequence comparison and alignment optimization have
grown in parallel to the comparative modeling field [50].
There are many ways to align protein sequences and
numerous methods to score the accuracy of the resulting
alignments. Homology modeling usually relies on one of
following three techniques: (a) standard pairwise
sequence alignment using dynamic programming, (b)
multiple sequence alignment when the target and tem-
plate sequences belong to a large family for which many
sequences and structures are known, and (c) direct align-
m e n to ft h es e q u e n c eo nt h es t r u c t u r eo ft h et e m p l a t e
using a threading technique. None of these techniques is
the panacea, especially when the sequence identity
between the target and template sequences is low. Errors
Figure 2 Impact of a misalignment in homology modeling. The target protein T0295 from CASP7 is modeled using the crystal structure of
human dimethyladenosine transferase (PDB 1ZQ9) as a template. In panel (A), we show the structural alignment of the template 1ZQ9 with the
best (yellow) and worst (blue) models generated by MODELLER 9v5 for T0295. The structural diversity between these models is low; Thr31 for
example superposes very well in the three structures. In panel (B), we show the effect of an error in the sequence alignment that serves as input
to the modelling process. We shifted the alignment by one residue at the level of Thr31, and generated new models for T0295. The
superposition of the template 1ZQ9 with both the best and the worst models shows locally a structural heterogeneity in the loop that contains
Thr31. Thr31 is being shift by 3.4 Å due to one single error in the sequence alignment.
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ment between the sequences of two proteins may not
match the alignment between their structures: this is
caused by the sequence alignment technique that opti-
mizes a score based on a substitution matrix and gap
penalties while structural alignment techniques optimize
geometric matching. There is no reason that these two
different metrics are equivalent. Errors are often frequent
in the loop regions between secondary structures, as well
as in regions where the sequence similarity is low. Recent
techniques that attempt to reduce the error rate in the
sequence alignment rely on the inclusion of as many
sources of information as possible, such as amino-acid
variation profiles, secondary structure knowledge, struc-
tural alignment data of known remote homologues,
knowledge of “anchor regions” (active-site catalytic resi-
dues or conserved motifs based on biological data). Many
programs also attempt to optimize the raw sequence
alignment derived from one of the techniques described
above. Most of these programs have been embedded into
web-servers for ease of uses, such as MUSCLE [51] and
Dialign-TX [52].
* Step 4: Loop building
The loop-building step is another key component in
homology modeling. Loops participate in many biological
events and functional aspects such as enzyme active sites,
ligand-receptor interactions, and antigen-antibody recog-
nition among others. However, due to the flexible nature
of loops, it is often difficult to predict their conformation.
There are two main approaches to tackle the problem of
loop modeling: methods that use databases of loop con-
formations or ab initio methods. In the database
approach, a library of protein fragments whose size cor-
responds to the size of the loop to be modelled is
scanned for fragments whose end-to-end distance
matches the corresponding distance in the framework.
The library is derived from the known protein structures
in the PDB. This method has proved to be accurate when
the loop is relatively short. Fidelis et al. have shown that
loops of a maximum of seven residues can be modelled
with confidence based on known structures [53]. When
the database method is combined with a restrained
energy minimization, it extends the confidence of loop
building up to nine residues [54]. Beyond the nine resi-
dues threshold, ab initio methods have to step in mostly
because for these longer loops, the fragment library pro-
vides a poor sampling of the conformational space acces-
sible. The ab initio loop prediction approach relies on a
conformational search guided by a scoring function. The
accuracy of ab initio loops modeling remains currently
low, especially when dealing with very long loops [55].
* Step 5: The side-chains positioning problem
The prediction of side-chain conformations for a given
backbone architecture remains a challenge. It is however
the key to generating models at atomic resolution. For
instance, critical side-chains forming an active site must
be accurately positioned in order to support any puta-
tive catalytic mechanism. Nearly all the side-chain posi-
tioning methods are based on rotamer libraries with
discrete side-chains conformations. Rotamer libraries
contain a list of all the preferred conformations of the
side-chains of all twenty amino acids, along with their
corresponding dihedral angles [56,57]. Some of these
rotamer libraries are further refined to account for the
local geometry of the backbone [58,59]. Sidechain pre-
diction techniques select the best rotamer for each resi-
due of the protein under study from one of these
libraries, based on a score that includes both geometric
and energetic constraints. This leads to a large combina-
torial problem: see Figure 3 for an example of the size
of the conformational space accessible to a sidechain in
a protein, even when we discretize this space by using
rotamers. The combinatorial problem is solved by heur-
istic techniques such as mean field theory, derivatives of
the dead-end elimination theorem or Monte Carlo tech-
niques [60]. The success rates of the most successful
techniques range from 78% to 89% for the c
1 and c
2
angles of residues in the core of the protein (i.e. residues
whose solvent accessibility is less than 30%). It is impor-
tant to note that these results usually relate to mock
experiments in which the exact conformation of the
backbone is known. It has been shown that the quality
of sidechain prediction decreases as the deviation
between the backbone used for modeling and the actual
conformation of the backbone increases [58,61]. These
results emphasize the need of a good framework (and
implicitly of a good sequence alignment between the
target and template protein) for homology modeling. It
is worth mentioning however that a 1Å accuracy over
the main-chain atom position can be related to X-ray
structures with 2.5 Å resolution and with a R-factor
around 25%, which is fairly common [62]. In addition,
multiple side chain orientations are routinely observed
in crystal structures and crystal-packing forces can alter
their positions as well. The side chain prediction meth-
ods are improving steadily, as reported by the CASP
experiments [63].
* Step 6: Refinement of the final model
In a review written in 1999 on the CASP3 experiment,
Koehl and Levitt noted that most models submitted in
the homology modeling category were not refined, as
previous CASP meetings had shown that refinement did
not improve the models [64]. Sadly for the computa-
tional biologists the situation has not improved and it
remains difficult to generate a model closer to the native
structure than the template used to build it [13]. Energy
refinement, originally introduced by Levitt and Lifson
forms the basis of current methodologies for protein
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Without experimental restraints, refinement by energy
minimization generally moves the protein structure
away from its X-ray structure. Some recent studies have
shown that this negative trend can be reversed through
the inclusion of evolutionary derived distance con-
straints [66] through the combination of sophisticated
sampling techniques based on replica exchange molecu-
lar dynamics and statistical potentials [67], through the
addition of a carefully designed, differentiable smooth
statistical potential [68], or by careful consideration of
the solvent effects [69]. While these studies are defi-
nitely source for hope, much work remains to be done
as far as refinement is concerned.
A general framework for model assessment: R-factors and
equivalent
The wide availability of homology modeling software
packages, as well as the development of web interfaces
that automate the use of these packages has resulted in
better access to and a broader usage of homology mod-
eling. While this is definitely commendable and homol-
ogy modeling should be even more advertised, there are
risks that this will lead to errors because of the difficul-
ties in evaluating the correctness of the models these
techniques generate. This is primarily due to the lack of
c r o s sv a l i d a t i o ni n d i c a t o r ss u c ha st h eR - f a c t o ra n dR -
free in X-ray crystallography [70]. In addition to the
stereochemistry assessmento ft h es t r u c t u r ea n dt h e
good correlation between the R-factor and the R-free
values, the quality of an X-ray structure can be evalu-
ated based on the thermal motion value of atoms
described by the Debye-Waller factor or B-factor. The
B-factor allows for the identification of zones of large
mobility or error like disordered loops. When multiple
monomers populate an asymmetric unit of a crystal, the
crystallographer will choose to focus on the analysis of
the monomer with the lowest average B-factor since the
likelihood of errors is lower. Unfortunately, such criteria
do not apply to models thus rendering the identification
of zones of uncertainties a non-trivial task.
With respect to homology modeling, the main step is to
thoroughly validate the model and always provide all the
relevant details about the protocol used. This will give the
user all the necessary data to judge the quality of
the model. The quality assessment of models has been the
focus of numerous studies and various algorithms have
been reported over the years. In this matter, tremendous
efforts are being made to produce the best triage
Figure 3 The side-chains positioning problem. We compare 10 models constructed for target T0295 with the native structure of T0295,
available in the PDB as file 2H1R (shown in red). We show only the backbones of each model and the native structure, except for the sidechain
of Tyr64. The diversity observed for the conformation of this sidechain emphasizes the difficulty to model sidechains accurately.
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the latest CASP meetings [71]. These scoring functions
are based on statistical potentials [72], local side-chain and
backbone interactions [73], residue environments [74],
packing estimates [75], solvation energy [76], hydrogen
bonding, and geometric properties [77]. In addition, it is
essential that the quality of stereochemistry be kept high.
The stereochemistry can be assessed by commonly used
programs such as Procheck or WhatIf [78,79].
Ultimately, the validation of models comes from
experiments such as site-directed mutagenesis, circular
dichroism, cross-linking, mass spectrometry, fluores-
cence-based thermal shift, light scattering, molecular
FRET or electron microscopy. Such experimental data
can be translated into constraints/restraints and intro-
duced in the modeling protocols thus improving the
accuracy of models. One can also identify fast and
cheap experimental procedures that can help testing
homology models. The easiest way is to crosscheck
models with experimental structures. For instance with
enzymes, it is possible to verify the location of impor-
tant catalytic residues in the active site by comparison
with homologous family members. Most importantly
however, a model needs to be checked manually in the
same way a NMR or an X-ray structure is processed.
Despite all these methods, the homology modeling
community still lacks a simple indicator which gives an
unambiguous feedback on how the final model, or
family of models, reflects the data that were used in the
modeling process, similar to the couple R-factor/R-free
for X-ray crystallography. The next section introduces
such an indicator, namely the H-factor.
Methods
Computing the H-factor
In this study, we introduce a novel indicator as an
a t t e m p tt oq u a n t i f yh o ww e l lah o m o l o g ym o d e lc o r r e -
lates with the input data and its biological relevance.
This indicator, the H-factor is designed to mimic the
R-Factor in X-ray crystallography. It is rooted in the
basics of homology modeling and it uses all data that
were included in the model building process to assess
its correctness, in addition to checking for good
stereochemistry. More specifically, the H-factor com-
bines information on (1) the template structure(s)
(based on the corresponding PDB files); (2) the
sequence alignment between the template(s) and the
target sequences; (3) the structural heterogeneity of
the models built; and (4) the structural neighborhood
within protein families. Note that at this stage, the
computation of the H-factor is based on a single fra-
mework. We plan to derive an extended H-factor that
will account for multiple templates. Each of these four
categories is assigned a scoring function returning a
value between 0 (best) and 10 (worst). The H-factor is
simply the sum of these scoring functions divided by
40. For ease of use, the H-factor is converted into a
percentage with a value between 0% (ideally the perfect
score) and 100% (the worst score). In par with the
R-factor in X-ray crystallography, a low H-factor value
indicates a trustworthy set of models, while a large
H-factor would raise a flag on the correctness of the
models. The H-factor focuses on the Ca-backbone as a
correct tracing is a prerequisite for a valid model. The
workflow of the H-factor calculation is detailed on
Figure 4A and 4B.
The scoring function (1) analyses the discrepancies
between the secondary structure prediction for the
Figure 4 Flowchart for computing the H-factor. A.T h es c o r i n g
functions (1) and (2) are sequence-based: score (1) compares the
secondary structure prediction for the target sequence with the
actual secondary structure assignment of the template protein,
while score (2) evaluates the sequence similarity between the target
and template sequence. B. The scoring functions (3) and (4)
evaluate the structural models: score (3) quantifies the structural
diversity among the models, while score (4) identifies the pfam
domain in the target protein, collects the structures of these
domains from the models to be tested, and compares these
structures with those observed for the same domains in the PDB.
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Page 9 of 19target obtained with the program psipred [80,81] and
the actual secondary structures of the template frame-
work computed with the program stride [82]. The corre-










































where the sum is computed over all positions in the
sequence alignment between the target and template, N
is the length of the sequence alignment, p is the second-
ary structure prediction of the target at position i
(values for p are ‘H’ for helix, ‘S’ for strands, and ‘C’
otherwise), c(i) is the confidence factor reported by
p s i p r e d( i n t e g e rv a l u e ,f r o m1t o1 0 )f o rt h es e c o n d a r y
structure prediction at position i and s is the secondary
structure type observed at position i in the template
structure reported by stride. The offset coefficients a
and b are set to 1.3 and 0.9, respectively, to ensure that
score (1) has values between 0 and 10.
The function (2) scores the identity between the
sequence of the target and the sequence of the template


































where N is the length of the sequence alignment.
The search for a template structure for a given target
protein sometimes finds multiple candidates. In addition,
considering multiple options for this alignment sometimes
alleviates ambiguities in the alignment between the
sequence of one of these candidates and the sequence of
the target. Both situations lead to multiple structural mod-
els being generated for the target protein: score (3) is
designed to measure the heterogeneity of this set of mod-
els. It uses as input all the models Mi, as well as the corre-
sponding average model, MA, whose atomic coordinates
are the averages of the corresponding coordinates in the
models. The average model MA is computed from the
structural alignment of all the models, which can be com-
puted for example with the cluster() function in MODEL-
LER [36] or with the program maxcluster [36,83]. The
function (3) then reports the average cRMS between each
model and the average model, where the cRMS is com-
puted over the Ca atoms only. The average cRMS is then
transformed linearly such that the final score is between 0
and 10:
score
























n is the number of models. The offset coefficients a
and b are chosen such that average RMS values of 0.1
and 7 Å correspond to scores of 1 and 10, respectively;
the corresponding values are a = 1.3 and b = 0.87.
The search for a template structure sometimes finds
partial matches. In many cases, this is related to the fact
that the target protein contains multiple functional
domains that may not always be associated in other pro-
teins. While the modeling is performed based on the
longest possible template, it is expected that each of
these domains have been correctly modelled. Score (4)
is designed to quantify this assertion. It first identifies
the various domains in the sequence, using HMMER
[84,85] and the pfam profiles database as a reference
[86], The average model MA is then broken down into
fragments corresponding to the domains that have been
identified. Each fragment is compared to the structure
of the same domain found in proteins whose structure
has been deposited in the PDB. A maximum of 5 frag-
ments is considered (the top 5 HMMER search results).
T om i n i m i z et h en u m b e r so ff a l s ep o s i t i v ew es e ta n
E-value cut-off of 1.0e-10 for hmmsearch. The score (4)
is then the average cRMS distance between the frag-
ments and their counterparts in the PDB:
score
























m is the number of functional domains identified in
the target sequence, MAd is the structural fragment
extracted from the average structure MA corresponding
to the domain d, n is the number of domains homolo-
gous to domain d found in PDB structures, and Dd,i is
the i-th possible structure of the domain homologous to
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that average RMS values of 0.1 and 7 Å correspond to
scores of 1 and 10, respectively; the corresponding
values are a =1 . 3a n db = 0.87. This usually enforces
that score (4) is between 0 and 10. Note that if this pro-
cedure does not find an equivalent domain for a frag-
ment, the fragment is ignored; if no domains are found
for all fragments, score (4) is ignored.
The H-factor computation is accessible online at
http://koehllab.genomecenter.ucdavis.edu/toolkit/h-fac-
tor with a simplified operating manual (Cf. additional
files). The source code is available upon request.
Testing of the H-factor on CASP targets
Target proteins that have been submitted to CASP
in the homology modeling category are perfect tests
for the H-factor measure presented here. The web site
for the Protein Structure Prediction Centre that
hosts all information about the CASP experiments
http://predictioncenter.gc.ucdavis.edu also includes a
database of all the models that have been submitted in
the successive CASP with the corresponding experimen-
tal structures. This database of CASP models contains
models that can be ranked from being very accurate to
being completely wrong. It is therefore ideally suited to
benchmark modeling techniques and to develop and test
validation methods. We have chosen three targets from
the recent CASP7 experiments: T0287, T0375 and
T0295 that have been identified as homology modelling
targets by the CASP organizers (see table 1 for details).
The first target (T0295) was considered “easy”, while the
second and third target (T0287 and T0375) were more
difficult cases for homology modeling. Fold recognition
techniques initially identified one template for T0287
and T0295, and six potential template structures for
T0375. The top templates were then selected according
to the CASP7 analyses of every possible template for
each target. We aligned the sequence of the target with
its template(s) using ClustalW [87], with the Gonnet250
matrix to define the substitution score and default set-
tings for gap penalties (Cf. additional files 1, 2). For the
first two targets, this corresponds to a simple pairwise
alignment, while for T0375, ClustalW provides a multi-
ple sequence alignment over the target sequence and
the six possible template sequences. We used MODEL-
LER 9v5 [36], with the “automodel” settings to generate
20 models for each of the three targets. As the H-factor
focuses only on the Ca-backbone, we did not attempt
to improve the prediction of the sidechains. In addition,
we did not perform any energy minimization of the final
model and it still remains unclear if energy minimiza-
tion improves models generated by homology modeling
[88].
Results and discussion
The H-factor: detailed analysis on three CASP targets
The CASP7 target T0295, a dimethyl adenosine trans-
ferase from Plasmodium falciparum is considered an
“easy” modeling case: it has a very close homologue
(sequence identity 46%) whose structure has been solved
at high resolution (PDB code: 1ZQ9, 1.9 Å resolution)
and in addition the template sequence covers the whole
sequence of T0295. We generated 20 models for T0295
using standard homology modeling techniques (see
methods). In this experiment, our goal was not to gener-
ate the ultimate, high-resolution model. Instead, we
were interested to see if the H-factor we have intro-
duced was able to measure the quality of the models we
generated. The average CRMS (based on Ca only)
between the T0295 models and the actual experimental
X-ray structure for target T0295 (available in the PDB
as 2H1R; resolution 1.89 Å) is 1.67 Å: this clearly indi-
cates that the models are of good quality. The corre-
sponding H-factor for these 20 models is 19%, i.e. a very
good score (by definition, H-factors vary between 0%
and 100%, with 0% being good and 100% being bad).
The good quality of the T0295 models is highlighted by
each scoring function included in the H-factor (Table 2).
The secondary structure prediction for T0295 matches
well with the actual secondary structure of its framework
(1ZQ9), yielding a value of 1 for score (1).T h es e q u e n c e
alignment between T0295 and 1ZQ9 is deemed good,
with a value of 1.9 for score (2). The 20 models generated
showed little structural dispersion with a corresponding







Coverage Type of sequence
alignment
Loop segments of 3 or
more residues
T0295 1ZQ9 (1.90) 46 1-275
(100%)
pairwise 80-86; 163-166; 179-182;
225-228; 271-275
T0375 2DCN (2.25); 1RKD (1.84);
1V1A (2.10);




multiple 33-37; 75-78; 100-103
T0287 1V55 (1.90) 16 1-199
(100%)
pairwise 33-37; 75-78; 100-103;
166-170; 197-199
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domain, PF00398 that corresponds to the ribosomal
RNA adenine dimethylase. In addition to being found in
the structure 1ZQ9, this domain is also found in the pro-
teins whose structures are available in the PDB files
1I4W, 1QAM, 1QYR, 1YUB and 2ERC. Score (4) com-
pared the structure of this domain in the models gener-
ated for T0295 and the structures of the same domain
found in all 5 proteins listed above. It detected fluctua-
tion between these structures, leading to a score of 3.8.
Note that the pfam domain PF00398 occurs in species
covering all three kingdoms. In addition, the structures
h a v eb e e nd e r i v e df r o md a t aw i t hw i d er a n g eo fr e s o l u -
t i o n( f r o m2 . 0Åt o3Åf o rt h eX - r a ys t r u c t u r e ;1 Y U Bi s
an NMR structure). It is therefore not surprising that
score (4) is relatively higher than the other scores; it does
remain however within a range that indicates a good
match. Note that the overall H-factor value is 19%. In
comparison, a R-factor of 20% is typically observed for
fully refined X-ray structures around 2 Å of resolution, i.
e. for a good X-ray structure.
When we deliberately introduce a shift at position 31
in the alignment between the sequence of T0295 and
the sequence of its template 1ZQ9 (see Figure 2), the
corresponding models generated by MODELLER show
structural diversity in the loop region near the shift (i.e.
near Thr31). Score (3) captures this structural diversity
within a set of models. It leads to the H-factor being
raised from 19% to 21% (see table 2). However, score
(2) could not detect a single position shift in the align-
ment. The H-factor is therefore capable of detecting
backbone deviation due to modeling errors, the same
way the R-factor does.
The CASP7 target T0375 is a more difficult modeling
case. It is a human ketohexokinase and the rigid-body
domain closure of sugar kinases is known to be large,
adding complexity into the modeling process [89].
Although several sugar kinase structures have been
solved, the search for templates for T0375 identified
only six distinct remote templates. Moreover, all six
templates are needed to obtain complete sequence cov-
erage of T0375 within one single framework with MOD-
ELLER. In addition, the template sequences have low
similarity with the target sequence. This is detected by
the scoring function (2),w h i c hr e t u r n sav a l u eo f8 . 6
(out of 10) (table 2). Note that the score (2) is not a
direct measurement of the quality of the sequence align-
ment. It is designed to quantify the difference between
the two sets of sequences: if this difference is small, the
model is expected to be good, while if the difference is
large, the sequence alignment most probably belongs to
the twilight zone and the models should then be consid-
ered with caution. The overall H-factor for the models
generated for T0375 is 41%. This mid-range value indi-
cates that caution should be used when interpreting or
using these models. Indeed, the average cRMS between
these models and the actual structure of T0387 (avail-
able in the PDB in the file 2HLZ) is 3 Å, i.e. reflecting a
medium-resolution agreement.
The CASP7 target T0287 is the most difficult test case
we have considered. In fact, it would not be considered a
homology-modeling target by many, despite the fact that a
(remote) structural homologue is available in the PDB. We
did decide to include it in our study to test whether the
H-factor was still providing useful information when
applied on a difficult test case. T0287 corresponds to
CaGS, a protein from Helicobacter pilori whose function is
unknown. A database search over all sequences of proteins
whose structure is known identifies a unique template,
1V55, with a low sequence identity (16%, see table 1).
1V55 is a Cytochrome C Oxidase and it is not clear that
T0287 and 1V55 are homologues. We did build 20 models
for T0287, using 1V55 as a template, and the out-of-the-
box alignment between the sequences of T0287 and 1V55
generated by ClustalW. As mentioned above, we did not
try to optimize the alignment or the modeling itself as our
Table 2 Comparing the H-factor with cRMS, DOPE and QMEAN scores to assess models generated for CASP7 targets
CASP 7 target Scoring function (a) H-factor (%) cRMS (Å) (b) % ID (c) DOPE (d) QMEANnorm (e)
(1) (2) (3) (4)
T0295 1.0 1.9 1.3 3.8 19 1.67 46 -33940 0.735
T0295* (f) 1.0 1.9 1.9 3.8 21 1.71 46 -24317 0.196
T0375 1.1 8.6 2.9 3.8 41 3.16 17 -28442 0.546
T0287 7.0 8.1 7.5 7.5 75 5.81 16 -18444 0.285
(a) The four scoring functions included in the H-factor measure the quality of the secondary structure prediction (score (1)), the diversity of the sequence
alignment (score (2)), the structural diversity of the models generated (score (3)), and the similarity of the predicted structures for the functional domains in the
target, compared to the structures of the same domains found in the PDB (score (4)) (see text for detail).
(b) Average cRMS (over Ca) between the 20 different models generated and the actual experimental structure for the target.
(c) Sequence identity between the target sequence and the template sequence.
(d) DOPE scores from MODELLER [94].
(e) QMEAN normalized score [95].
(f) T0295* is the toy experiment in which the sequence alignment between the target T0295 and its framework has been deliberately modified (see text for
details).
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Page 12 of 19interest is to see if the H-factor is able to assess the quality
of the models we generated. In this specific case, all four
scores reported high values (7.0, 8.1, 7.5 and 7.5 for scores
(1), (2), (3) and (4), respectively). The overall H-factor is
75%, a valued that should raise concerns about the quality
of these models. As for target T0375, this is confirmed by
the experiment: the average cRMS between these models
and the actual structure for T0287 (PDB code 2G3V) is
5.8 Å, indicating that the models are poor approximations
of the native structure.
H-factor: Detecting bad models
From the three test cases T0295, T0375 and T0287, we
conclude that the H-factor correlates well with the qual-
ity of the models tested. To further confirm that high
H-factor values correspond to models that should be
considered with caution, we downloaded sets of models
for seventeen target proteins from CASP7. These targets
were considered as difficult, with only remote templates
available. The corresponding sets of models, available
from the CASP web site have poor to bad quality.
When compared to the actual experimental structures,
these models have a very high cRMS indicated major
errors in the backbone tracing. In all sixteen cases, the
H-factors are found to be high, as shown in table 3.
H-factor: characterizing good models
The H-factor computes the quality of models for protein
structure based on sequence information (score (1) and
score (2)), as well as based on structure information (score
(3) and score (4)). While the former is specific to homol-
ogy modeling, the latter can be used to assess the quality
of any sets of models. We tested score (3) and score (4) on
a random set of NMR structures for which 10 or more
models are available. In this validation case, the H-factor is
the sum of functions (3) (4) divided by 20 instead of 40,
and converted to percentage. Results are listed in Table 4.
In every case, the H-factor is low and below 35% in aver-
age, as anticipated. This indicates that the algorithm
recognized the experimental structures as valid.
Although the H-factor and the R-factor are mathe-
matically unrelated, they have the same purpose: to
assess the quality of structures, either experimental or
computed from modeling experiments, where quality
refers to reflecting correctly the input data used to
generate these structures. The H-factor mimics the
R-factor as it provides a quality-index to follow in the
process of building a model, the same way crystallogra-
phers monitor the R-factor/R-free indexes during
structures refinements. We compared the H-factor
results with the experimental R-factor and R-free on a
randomly chosen subset of the PDB containing 445
structures with 6 or more identical chains solved by
X-ray crystallography. Results are shown in Figure 5.
The H-factor and R-factor are not linear correlated but
it remains that “good” R-factors (below 30%) corre-
spond to “good” H-factor values (below 45%). The H-
factor checks the diversity of the set of models gener-
ated for a structure, as well as their similarities with
the structures of domains that share the same func-
tion, as defined by pfam. High H-factor values may be
caused by structures with disordered loops or remote
structural neighbors in the PDB. It remains that, in
agreement with what we observed for the NMR struc-
tures, the H-factor recognizes experimentally deter-
mined structures as being valid.
Table 3 Comparison of the H-factor with cRMS, DOPE
and QMEAN scores to assess models generated for











T0356_D1 48 4.9 -8908 0.242
T0356_D2 48 4.9 -13013 0.209
T0316_D3 49 6.0 -5488 0.176
T0356_D3 49 4.9 -9274 0.285
T0316_D2 51 5.8 -2980 0.110
T0307_D1 62 5.5 -12623 0.385
T0307 63 6.0 -13816 0.407
T0309 65 5.5 -4613 0.180
T0314 65 5.4 -9248 0.372
T0296 67 5.6 -35782 0.260
T0299 67 5.9 -17649 0.334
T0306 68 4.8 -7884 0.287
T0316_D1 68 5.6 -16102 0.214
T0299_D2 69 6.0 -7742 0.302
T0316 69 3.8 -31249 0.172
T0299_D1 70 6.2 -7641 0.250
(a) cRMS (over Ca) between the average model and the actual experimental
structure for the target.
(b) DOPE scores from MODELLER [94].
(c) QMEAN normalized score [95].
Table 4 H-factor applied to NMR structures with
20 models or more
PDB id Scoring function (a) H-factor (%) cRMS (Å) (b)
(1) (2) (3) (4)
1A5E 1.03 n/a 2.13 3.43 28 1.95
1A2I 1.24 n/a 1.48 3.8 34 2.29
1A24 0.74 n/a 2.27 4.5 38 2.79
1A57 1.38 n/a 2.33 4.67 35 2.91
1A5J 0.99 n/a 2.38 4.67 35 2.91
1A67 0.37 n/a 2.67 4.8 37 3.03
(a) See text for the description of the scoring functions (3) and (4); these two
functions measure the structural dispersion of the models considered, as well
as their similarities to homologue structures in the PDB; note that scores (1)
and (2) usually present in the H-factor are meaningless for this test set.
(b) Average RMS between each model and the “mean” structure computed
from all the models.
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The cRMS by itself is a reasonable quality indicator as
long as its value remains low (say below 2 Å). It should
be noted that it is an average value computed over the
whole structure. As such, it is very sensitive to large
structural fluctuations in disordered loops for example
that can lead to large cRMS values even if the con-
served domains are structurally very similar. It is well
known for example that caution should be applied
when using cRMS to assess the quality of a structural
alignment. cRMS is implemented in score (3) of the
H-factor to evaluate the heterogeneity amongst a set of
models as it is directly related to both the choice of the
template and the quality of the sequence alignment.
However, the score (3) loses accuracy for cRMS values
larger than 2 Å, which is not uncommon when a
remote template is used. cRMS is also implemented in
score (4) to quantity the modelling quality of specific
individual domains by comparing them with corre-
sponding domains in the PDB. This is a domain-based
cRMS that does not take into account potential long
loops between domains, making it more reliable. Taken
together, the scores (3) and (4) alleviate most of the
limitations of cRMS while retaining its major properties.
The H-factor is therefore expected to be more reliable
than a sole cRMS to judge the accuracy of a wide range
of models, as seen in Table 3.
Comparing the H-factor with ProSA, DOPE and QMEAN
The structural biology community as well as the protein
structure modeling community have always been rea-
sonably good at setting safeguards to estimate the valid-
ity of both experimental and computational models for
protein structures. The first validation tests imposed on
experimental structures focused on the stereochemistry
of the molecules. It was found, however that this was by
far not sufficient, as “good stereochemistry” can be mis-
leading. A “clean” Ramachandran plot for example does
not necessary prove that a given model is valid. Also, we
observed that all the models listed in Table 1 have good
stereochemistry, including the T0287 model that has a
Ca backbone deviation of almost 6 Å from the actual
experimental structure. Experimentalists have access to
another essential set of validation tools that check the
consistency of the structures with the experimental data
that were used to derive them. Such tools include the R
factors in X-ray crystallography and NMR. Models
derived from modeling experiments are more difficult to
verify, unless they include some external information.
For example, the SWISS-model server provides a confi-
dence score along with the models it built and this con-
fidence score is based on the amount of structural
information that supports each part of the model
[38,90]. In general, however, validation of computer-gen-
erated models is based on comparison with known pro-
tein structures. The idea is that basic properties of
protein structures can be inferred from the PDB, and
translated into database-derived scoring functions. This
is the main rational for the statistical potentials, also
referred to as mean-field potentials that have become
very popular validation tools [67,91,92]. For example,
ProSA-web implement two statistical potentials: a pair-
wise potential based on Cß atoms and a surface term
that models the protein-solvent interactions [93]. Here
we compare the output of ProSA and H-factor analyses
on the three CASP7 test cases given in table 1. The
ProSA results are given if Figure 6. Both the H-factor
and ProSA estimate that the models generated for
Figure 5 Comparison between the H-Factor and the experimental R-factor and R-free. A set of 445 randomly chosen X-ray crystallography
structures of 6 or more identical chains have been scored with the H-factor and results are compared to both the experimental R-Factors and R-
Frees. R-values are scaled in the interval [0,100%] to allow for direct comparison. Note that we computed a H-factor only from functions (3) and
(4) since scores (1) and (2) that are usually in the calculation of the H-factor are meaningless for this test set.
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Page 14 of 19Figure 6 Comparison between the H-Factor and ProSA. ProSA-Web analysis of the average model generated for three CASP7 targets:
A. T0287 and T0375. B. T0295 and T0295*. The test case T0295* corresponds to T0295 with a modified sequence alignment used to generate
the models (see figure 2 for details). The H-factors for the same models are given for comparison.
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ately altered (test case T0295*, see above for details),
again both ProSA and the H-factor analyses reveal a
loss of quality. ProSA however considers the models
generated for the targets T0287 and T0375 as statisti-
cally correct (i.e. within range of what is observed in
native proteins), while we know that these models are
not correct (see table 2). In addition, it is striking to see
t h a tt h eP D Bs t r u c t u r e1 U S 0 ,a nu l t r ah i g h - r e s o l u t i o n
crystal structure at 0.66Å resolution, has a ProSA
Z-score (-12.27) statistically as correct as T0287 (data
not shown).
The statistical potential Discrete Optimized Protein
Energy (DOPE) is another measure of model quality that
has been introduced in MODELLER-8 [94]. DOPE is a
statistical potential with an improved reference state that
accounts for the compact shape of native protein struc-
tures. The DOPE score is designed such that large, nega-
tive scores are usually indicators of good models. In their
original study, Shi and Sali [94] found that the accuracy
of DOPE to asses a homology model improves as the
accuracy of the models improve. We observe a similar
behaviour for targets T0295 and T0295* (Table 2). These
two targets correspond to the same protein and it is
therefore possible to compare the DOPE scores of their
models. The model generates for T0295*, based on an
incorrect alignment, has a much lower DOPE score
(-24317) that the model generated with the correct align-
ment (T0295;-33940). Note that we cannot compare
DOPE scores for proteins of different size, as these scores
are not normalized. DOPE scores are therefore relative,
and designed to pick a “good” model among poorer
model. DOPE scores do not assess directly the quality of
the model that is picked, i.e. if it is likely to be similar to
the actual structure. The H-factor is a better indicator in
that respect.
QMEAN, which stands for Qualitative Model Energy
ANalysis, is a composite scoring function for homology
models that describes the major geometrical aspects of
protein structures (including a torsion angle potential
over three consecutive amino acids, a secondary struc-
ture-specific residue-based statistical potential, a solva-
tion potential for the burial of residues) as well as the
agreement between the predicted and calculated second-
ary structure and solvent accessibility, respectively [95].
As such, it includes a term similar to the score (1) of
the H-factor, as well as terms that assess different prop-
erties such as residue accessibility. The score QMEAN-
norm is a normalised version of the QMEAN score in
which all terms are divided by the number of interac-
tions/residue in order to avoid a size-bias of the score
[95]. QMEANnorm scores vary between 0 and 1, with
larger scores expected to correspond to better models.
Unlike the DOPE score, both the H-factor and
QMEANnorm scores allow for the comparison of pro-
teins of different sizes. The QMEANscore is as effective
as PROSA or DOPE for detecting errors in a model that
result from errors in the sequence alignment between
the template and target protein: T0295* has a QMEAN-
norm score of 0.196 while the score forT0295 is 0.735
(Table 2). Interestingly, T0295* (0.196) has a less favor-
able QMEANnorm score than the erroneous model gen-
erated for the CASP target T0287 (0.285) (see table 3).
We have observed however that the QMEANnorm
score is prone to fail: some of the erroneous models
generated for the CASP target T0307 have QMEAN-
scores of 0.4 to 0.6, i.e. they are evaluated to be almost
as correct as the positive control T0295 (0.735). Unlike
P r o S Aa n dQ M E A N ,t h eH - f a c t o rd i dd e t e c tt h a tt h e s e
models were to be considered with caution. Because it
analyzes a set of models, we believe that the H-factor
score is more robust as an absolute measure of the qual-
ity of a model. It lacks however the ability to discrimi-
nate among a set of models generated for the same
target; PROSA and DOPE are better potentials for this
specific task.
These results emphasize the essential differences in
the nature of the ProSA, DOPE, QMEANnorm and
H-factor scores. ProSA, DOPE and QMEAN check the
quality of a model, independently of the context in
which it was generated. The H-factor on the other hand
checks the quality of a set of models with respect to a
context that includes for example the sequence align-
ment assessed by the score (2). The modeler however
should use these differences to extend his/her assess-
ment of the model his/she generates. We believe that
ProSA, DOPE, QMEAN and H-Factor analyses are
needed to provide a better overview of the quality of
models derived by homology modeling.
Current limitations and originalities of the H-factor
The H-factor is not the panacea, and does not provide
a universal solution to the problem of asserting the
quality of a model generated by homology modeling.
Firstly, the H-factor has some technical limitations.
Our current implementation does not take into
account multiple templates, but rather only one single
framework. The structural components included in
the H-factor (i.e. scores (3) and (4))a r eb a s e do nt h e
backbone of the models, and do not take into account
sidechains and possible errors in their modeling. Sec-
ond, the scoring function (3) of the H-factor measures
the heterogeneity of a set of models generated with
the same input. It means, that the H-factor cannot be
computed on a singular model. In homology modeling
the heterogeneity of models can be seen as a quality
indicator and building only one single model is not
recommended. Similarly to NMR structures where
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best model in homology modeling regime is chosen
based on the MODELLER energy function for
instance. Third, the H-factor does not include any
external information. For example, if some biological
data are available, such as the knowledge of the resi-
dues involved in the active site, or standard biophysi-
cal data such as melting temperature, or secondary
structure content derived for circular dichroism, these
data are currently not included in the H-factor
analysis.
The R-factor is a measure of the agreement between
the crystallographic model and the experimental X-ray
diffraction data. Despite the lack of ‘experimental’ data
to compare with, the modelling community has been
searching for a similar indicator for homology modeling.
Both QMEAN and the H-factor are designed to be
‘absolute’ indicators that assess the quality of homology
models in a way that mimics the R-factor in X-ray crys-
tallography. Both QMEAN and H-factor provide an
easy-to-use estimate of the quality of models based on
scoring functions assessing various aspects of the model-
ling process as well as the model itself [95].
In vivo macromolecular structures oscillate between
numerous conformers, some more than others. While
X-ray structures correspond to snapshots of a limited
numbers of conformers, NMR structures tend to
describe more accurately flexibility. Indeed, NMR “struc-
tures” are usually provided as a family of conformers
that are meant to sample the conformational space
accessible to the molecule of interest. In homology
modeling on the other hand, the heterogeneity of mod-
els is a quality indicator. A good set of models will have
ac R M Sv e r yc l o s et ot h e i rf r a m e w o r k .M o r e o v e r ,i f
errors are being made in the template choice or in the
sequence alignment, then the models will be heteroge-
neous. The scoring function (3) is designed to quantify
this assertion. It also means that the H-factor cannot be
computed on a single model.
One of the originality of the H-factor is the scoring
function (4). It has been designed to evaluate the biolo-
gical relevance of the models by comparing the model
conformations of all the functional domains in the pro-
tein considered with the existing sibling deposited in the
Protein Data Bank.
We acknowledge that there is room for improvement.
However, It remains that the H-factor we have intro-
duced here is a first step in the direction of validating
homology models for the biologists in addition to exist-
ing methods, as proved in the examples shown above.
Conclusions
Homology modeling is slowly building up a record of suc-
cess and can help structural biologists in many aspects.
Models can serve as a bootstrap structure for both NMR
and X-ray crystallography and thus help saving a huge
amount of time. In X-ray crystallography for instance,
many derivative dataset are often needed to solve the
phase problem. Alternatively, an accurate bootstrap would
be extremely handy for molecular replacement. The same
applies for NMR. Protein modeling is also crucial for fit-
ting low resolution electron microscopy maps or building
accurate models using structural restraints gathered with
small-angle X-ray scattering (SAXS) experiments. Models
can be used at different level of details according to their
accuracy. In the absence of experimental structures, they
serve as starting points for modeling experiments, such as
molecular dynamics studies, docking experiments and
structure-based drug design. For instance, models of
membrane proteins such as G-protein-coupled receptor
(GPCR) are extensively used, as few structures are avail-
able for this protein family [96].
In this study, we proposed a modeling etiquette that
hopefully will help make good use of models. We
introduced the H-factor, a new indicator that assesses
the quality of models generated by homology model-
ing, mimicking the R-factor in X-ray crystallography.
The H-factor is able to detect backbone anomalies as
well as give a feedback on the biological relevance of
models. The H-factor evaluates the quality of a pro-
tein model within the context in which it is modelled
and we believe it is an essential tool that needs to
be used in addition to the other validation tools
available.
Note
To search for protein structures using any of the acces-
sion numbers mentioned in this article, please follow
this link (http://www.rcsb.org/pdb/home/home.do).
Additional material
Additional file 1: Sequence alignments used to build models for
CASP7 targets used to test the H-Factor. Sequence alignments for (1)
T0287; (2) T0295 and (3) T0375 respectively.
Additional file 2: A simplified operating manual for the H-Factor.
Operating manual for the online H-Factor server.
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